期刊文献+

难治性癫痫患者脑组织中SCG10的表达及其意义 被引量:1

Up-Regulation of Superior Cervical Ganglia Neural-Specific 10 Protein in the Brain of Patients with Intractable Epilepsy
原文传递
导出
摘要 目的了解难治性癫痫患者脑组织中SCG10和MAPK的表达,探讨其在难治性癫痫发生、发展中的作用。方法按随机化原则,在我们建立的难治性癫痫患者术后脑组织库中抽取36例患者的脑组织,用免疫组织化学分别检测SCG10和MAPK的表达,与16例对照组进行比较。并采用免疫荧光双标的方法,检测SCG10和MAPK在病例组中的表达情况。结果免疫组化检测到SCG10在实验组表达(0.4674±0.0258),高于对照(0.3405±0.0207),两组比较有显著性差异(P<0.05);MAPK在实验组表达(0.4217±0.0141),同样也高于对照组(0.3189±0.1422,P<0.05)。免疫荧光双标法,显示SCG10和MAPK表达在同一细胞上。讨论 SCG10与MAPK在难治性癫痫患者的脑组织中表达增加,以及它们的共同表达,提示两者的相互作用可能是难治性癫痫发生发展中的一个重要因素。 Objective To investigate the expression of SCG10 (Superior cervical ganglia neural-specific 10) and MAPK( Mitogen Actived Protein Kinase) in brain tissue of patients with intractable epilepsy so as to explore the possible roles of them in the pathogenesis of intractable epilepsy. Methods The brain tissues of intractable epilepsy patients (n = 36) was collected. Expression of SCG10 and MAPK were detected by immunohistochemistry, all results were compared with normal control , and we investigated the relationship between SCG10 and MAPK by double-label immunofluorescence staining in the IE group. Result The SCG10 staining intensity of immunohistochemistry in the intractable epileptic tissue was ( 0. 4674 ± 0. 0258 ) was significantly higher than those in the control group (0. 3405 ± 0. 0207, P 〈 0. 05 ), the express- tion of MAPK (0. 4217 ±0. 0141 ) was also higher than those in the control group (0. 3189 ±0. 1422,P 〈0. 05). And by double-label im- munofluorescence staining,we investigated the expression of SCG10 and MAPK occurred in the same neuron. Conclusion The results indicate that SCG10 and MAPK overexpression and co-expressionn , the interaction of them may play an important role in the epileptogenesis of intractable epilepsy.
出处 《世界科技研究与发展》 CSCD 2010年第2期239-242,共4页 World Sci-Tech R&D
关键词 难治性癫痫 SCG10 MAPK intractable epilepsy ( IE ) superior cervical ganglia neural-specific 10 protein ( SCG10 ) mitogen actived protein kinase(MAPK)
  • 相关文献

参考文献2

二级参考文献19

  • 1汪建华,王学峰,龚云,晏勇,栾国明,王玉平,李云林,张建国,卢涌,李红卫.耐药性癫癎患者术后脑组织中Tau蛋白的表达[J].中华神经科杂志,2005,38(9):543-546. 被引量:9
  • 2Widmann C,Gibson S,Jarpe MB,etal.Mitogen-activated protein kinase:conservation of a three-kinase module from yeast tohuman.Physiol Rev,1999,79:143-180.
  • 3Charest DL,Mordret G,Harder KW,et al.Molecular cloning,expression,and characterizationof the human mitogen-activated protein kinase p44erk1.Mol Cell Biol,1993,13:4679-4690.
  • 4Hobson SA,Wright J,Lee F,et al.Activation of the MAP kinase cascade by exogenouscalcium-sensing receptor.Mol Cell Endocrinol,2003,200:189-198.
  • 5Impey S,Obrietan K,Storm DR.Making new connections:role of ERK/MAP kinase signaling inneuronal plasticity.Neuron,1999,23:11-14.
  • 6Berkeley JL,Decker MJ,Levey AI.The role of muscarinic acetylcholine receptor-mediatedactivation of extracellular signal-regulated kinase 1/2 in pilocarpine-induced seizures.JNeurochem,2002,82:192-201.
  • 7Jeon SH,Kim YS,Bae CD,et al.Activation of JNK and p38 in rat hippocampus after kainicacid induced seizure.Exp Mol Med,2000,32:227-230.
  • 8Chu CT,Levinthal DJ,Kulich SM,et al.Oxidative neuronal injury.The dark side ofERK1/2.Eur J Biochem,2004,271:2060-2066.
  • 9Adams JP,Anderson AE,Varga AW,et al.The A-type potassium channel Kv4.2 is a substratefor the mitogen-activated protein kinase ERK.J Neurochem,2000,75:2277-2287.
  • 10Jiang W,Van Cleemput J,Sheerin AH,et al.Involvement of extracellular regulated kinaseand p38 kinase in hippocampal seizure tolerance.J Neurosci Res,2005,81:581-588.

共引文献120

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部